• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
SLDB

SLDB

Solid Biosciences Inc.

NASDAQHealthcareBiotechnologyUS

USD6.85

+0.27 (+4.10%)

Rating:C+

Company Profile

CEO

Alexander G. Cumbo

IPO Date

2018-01-26

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$6.86

Prev. Close

$6.58

Day Low

$6.74

Day High

$6.97

52W Low

$3.67

52W High

$8.87

Market Cap

$0.53B

Volume

1.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.0%

Avg Negative

12.0%

Avg Neutral

57.9%

News Feed

Solid Biosciences Reports Inducement Grant to New Senior Vice President, Clinical Development

GlobeNewsWire·7/2/2021·↑ positive

Solid Biosciences Reports Inducement Grant to New Chief Regulatory Officer

GlobeNewsWire·6/7/2021·↑ positive

Solid Biosciences Announces Appointment of Iman Barilero, PharmD, Ph.D., as Chief Regulatory Officer

GlobeNewsWire·6/7/2021·↑ positive

Solid Biosciences to Present at Upcoming Scientific Conferences

GlobeNewsWire·5/25/2021·↑ positive

Solid Biosciences' (SLDB) CEO Ilan Ganot on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/14/2021·↓ negative

Solid Biosciences (SLDB) Stock: Over 20% Decrease Explanation

Pulse2·5/14/2021·↓ negative

Solid Biosciences Provides First Quarter 2021 Business Update and Financial Results

GlobeNewsWire·5/14/2021·↑ positive

Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit

GlobeNewsWire·4/20/2021·↑ positive

Solid Biosciences to Participate at Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day

GlobeNewsWire·3/25/2021·↑ positive

Should You Buy Solid Biosciences (SLDB) Ahead of Earnings?

Zacks Investment Research·3/24/2021·↑ positive